Crossmark

Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes

Crossref DOI link: https://doi.org/10.1038/s41409-025-02776-y

Published Online: 2025-12-10

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sheikh, Irtiza N. https://orcid.org/0000-0003-4869-8818
Alqahtani, Shaikha

Okeleji, Olayinka

Brown, Brandon D.

Ragoonanan, Dristhi

Waseemuddin, Mohammed

Shoberu, Basirat

Kawedia, Jitesh

Khazal, Sajad J.

Connors, Jeremy https://orcid.org/0000-0003-2817-8890
Petropoulos, Demetrios

Tewari, Priti

Bonfim, Carmem

Driscoll, Timothy A.

DePriest, Brittany Paige

Mahadeo, Kris M. https://orcid.org/0000-0003-2649-9674
License Information

Text and Data Mining valid from 2025-12-10

Version of Record valid from 2025-12-10
More Information

Article History

Received: 21 August 2025

Revised: 4 November 2025

Accepted: 19 November 2025

First Online: 10 December 2025

Competing interests

: The authors declare no competing interests.

: All methods were performed in accordance with the relevant guidelines and regulations. Informed consent for treatment was obtained from all participants. The study was approved by Duke University (Pro00116394) and University of Texas at MD Anderson Cancer Center (2002-0063) institutional review boards, respectively.

Document is current

Any future updates will be listed below